Drug pricing, clinical trial data, FDA approvals, NPI provider directories, and hospital information from public US health data sources — structured for pharma, payers, providers, and health technology teams.
Healthcare is one of the highest-value verticals for US web scraping — pharma intelligence, payer analytics, health system competitive insight, and digital health platforms all need access to public health data at scale. We extract from FDA, ClinicalTrials.gov, NPI registry, drug pricing sites, hospital directories, and public regulatory sources. We work strictly with public data and do not handle patient-level PHI.
Brand and generic drug prices across US pharmacies, GoodRx tiers, manufacturer list prices, and pricing variation by geography.
Active and completed clinical trials from ClinicalTrials.gov with phase, sponsor, condition, intervention, status, and enrollment data.
Recent FDA approvals, drug pipeline status, generic entry dates, biosimilar approvals, and recall notifications.
National Provider Identifier records with provider name, specialty, location, group affiliation, taxonomy codes — fully public dataset.
Hospital names, addresses, bed counts, system affiliations, service lines from public CMS data and hospital websites.
Where surfaced publicly, payer formulary status, tier placement, and prior-authorization requirements.
| Source | Entity Type | Name | Category | Status | Location | Update Date | Captured (UTC) |
|---|---|---|---|---|---|---|---|
| ClinicalTrials.gov | Trial | NCT05XXXXXX — Diabetes Type 2 Drug X | Endocrinology | Phase 3 Active | Multi-site US | 2026-05-15 | 2026-05-19 10:30 |
| NPI Registry | Provider | Dr. M. Johnson, MD | Cardiology | Active | Boston, MA | 2026-04-22 | 2026-05-19 10:30 |
| FDA | Approval | Drug Y (manufacturer A) | Oncology | Approved | — | 2026-05-12 | 2026-05-19 10:30 |
Sources we typically cover: FDA.gov · ClinicalTrials.gov · NPPES NPI Registry · CMS Hospital Compare · GoodRx (public pricing) · Hospital websites · Drugs.com · Public pharmaceutical announcements
Track competitor pipeline, FDA approval timing, generic entries, and pricing dynamics across drug classes.
Build provider directories, drug databases, and clinical decision support tools on top of structured health data.
Cross-payer formulary comparison, drug pricing benchmarks, and provider network analysis.
Track health system M&A signals, pharma pipeline progress, and digital health platform growth indicators.
30-min call to confirm sources, fields, frequency, and output schema.
Sample dataset delivered for your team to validate coverage and quality.
Scheduled jobs, monitoring, retries, reporting — backed by uptime SLA.
We work strictly with publicly available data (FDA publications, NPI registry, public clinical trial records, public drug pricing). We do not access, process, or deliver any protected health information (PHI). HIPAA primarily governs PHI handling — not public regulatory data.
No — we do not scrape, deliver, or handle patient-identifiable information of any kind. Our scope is public regulatory, provider directory, and pricing data only.
FDA approval notifications are captured within 24 hours of public posting. ClinicalTrials.gov updates are tracked daily.
Our primary coverage is US-focused (ClinicalTrials.gov, FDA). International trial data via EU CTR or ICH sources can be added on request.